COVID dealt Canada’s multiple sclerosis community a major blow—it’s time to close the gap

A new report reveals nearly $600-million in additional costs from the pandemic health-care system disruption through a blend of delayed MS diagnosis, and delayed or foregone treatment.
Mark Holland
Federal Health Minister Mark Holland and his counterparts in other orders of government should prioritize dedicated research funding that focuses on prevention and treatment strategies and boosts to MS specialist care, writes Pamela Valentine.

For many Canadians, the COVID-19 pandemic is something they never want to think about again—a bad dream of isolation, social disruption for our children, economic hardship or failure for our businesses, and the mental stress of working and learning from home. But post-pand...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES